The slip
PARKINSON RECEIPTno. 4707
20 Oct 2026, 23:37 UTCdopamine neurons, braak
predictionVPS13A in dopamine neurons tracks Braak Lewy-body stage
registered2a79f25fd9449256
discovery+0.55 p=0.122 n=9
replication+0.42 p=0.258 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.55, p 0.122)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT97d0ff00b6778ba6d0bbfe52…
follows 6b42b7915d5c…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 4707: VPS13A in dopamine neurons, braak
- power
- full sample +0.49 (p 0.040, n 18), 95% CI +0.03 to +0.78. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: +0.51 (p 0.030, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.57 (p 0.014, n 18). not the mix.
- skeptic
- leave-one-out range +0.43 to +0.67, sign flips 0; without severely affected donors +0.49 (p 0.040, n 18). robust.
- cell type
- strongest in OPCs: -0.62 (p 0.0057, n 18) vs +0.49 in dopamine neurons. proposing OPCs.
- axis
- no measure beats "tracks Braak Lewy-body stage" for VPS13A in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up VPS13A · OPCs · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.60 p 0.033 (needs p < 4.2e-4)